CClinicalTrials.gg
RecruitingNCT06416059Updated Jun 17, 2024

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

An interventional study of Mobile Application in Alcohol Abuse and Anxiety, sponsored by University of Houston. Recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2024-06-17.

Sponsored by University of Houston · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Registered 11 months after the study started (first participant enrolled May 2023, registered May 2024).
  • Started May 2023; still recruiting 3 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Study summary

The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.

Read the detailed description

Investigators will develop a culturally adapted, brief, single-session PFI delivered via a mobile health application for the Android and iOS platform through an iterative approach using expert input and semi-structured interview sessions. Next, Black hazardous drinkers with clinical anxiety will assess program navigation and conduct usability testing. Finally, Black hazardous drinkers with clinical anxiety will be recruited to complete the final prototype of the mobile health application in order to evaluate the feasibility, acceptability, and initial effects. Initial screening will be conducted via Zoom; baseline and post-treatment data will be collected via Zoom and 1-week, 1-month, and 3-months follow-up data will be collected remotely.

02

Conditions studied

  • Alcohol Abuse
  • Anxiety

Browse trials for

Keywords

  • African American
  • Black
  • Personalized Feedback Intervention
03

In context

Alcoholism

1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.

This study's planned enrollment of 50 is below the median of 87 across 1,371 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

University of Houston is the lead sponsor of 101 studies on the registry; 17 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 3 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being 21 years of age or older
  • Self-identifying as Black or African American
  • Meeting criteria for current hazardous drinking pattern
  • Meeting criteria for clinical anxiety
  • Being able to provide written, informed consent
  • Owning a smartphone.

Exclusion criteria

Exclusion Criteria:

  • Current participation in alcohol or other substance abuse treatment
  • Engaged in psychotherapy for anxiety or depression
  • Concurrent use of medication for anxiety or depression
  • Being pregnant by self-report
  • Residence outside of the United States confirmed via survey geolocation
  • Inability to provide a valid United States-issued driver's license or identification card to verify identity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Mobile Application

    Participants complete a 45 minute intervention at baseline and will have access to intervention material for up to 3-months after the baseline appointment via the mobile health application.

    Behavioral: Mobile Application

Interventions

  • BehavioralMobile Application

    The mobile application is a culturally adapted, brief, personalized feedback intervention (PFI) to address alcohol misuse in the context of clinical anxiety,

06

What researchers measure

Primary outcomes

  1. Alcohol Use Disorders Identification Test

    The Alcohol Use Disorders Identification Test will be used to assess drinking quantity, craving, and related consequences to alcohol use. The 10 items are rated with various Likert-type scales. The measure produces a total score by adding all of the items of the measure with higher scores indicating greater problems with alcohol (possible range 0 to 40). A higher score indicates a worse outcome.

    Time frame: Change from Baseline Pre PFI Completion to 3-months Post PFI Completion

  2. Overall Anxiety Severity and Impairment Scale

    The 5-item Overall Anxiety Severity and Impairment Scale will be used to assess anxiety symptom severity and impairment. Each of the items is rated on a Likert-type scale ranging from 0 to 4. Items are summed to produce a total score (possible range 0 to 20). A higher score indicates a worse outcome.

    Time frame: Change from Baseline Pre PFI Completion to 3-months Post PFI Completion

Secondary outcomes

  1. Motivation to Reduce Alcohol Consumption Scale

    The 1-item Motivation to Reduce Alcohol Consumption Scale will be used to measure current motivation/intention to reduce alcohol. Participants will be asked to select the statement that best describes their motivation/intention to reduce drinking (e.g., "I really want to cut down on drinking alcohol and intend to in the next month"). Higher scores on this measure indicate greater motivation/intention to reduce alcohol consumption (possible range (0-7).

    Time frame: Change from Baseline Pre PFI Completion to 3-months Post PFI Completion

  2. Modified Drinking Motives Questionnaire-Revised

    The Modified Drinking Motives Questionnaire-Revised will be used to assess expectancies of drinking. For the current study, the 28-item questionnaire will be used as a measure of expectancies of drinking to reduce/cope with anxiety. The measure utilizes a 5-point Likert scale ranging from 1 (almost never/never) to 5 (almost always/always). Scores are averaged with higher scores indicating greater expectancies of drinking to reduce/cope with anxiety (possible range 1 to 5).

    Time frame: Change from Baseline Pre PFI Completion to 3-months Post PFI Completion

  3. Alcohol Attitudes Scale

    The 7-item Alcohol Attitudes Scale will be utilized to measure maladaptive attitudes for drinking (e.g., "Drinking alcohol is good"). Items are rated on a Likert-type scale from 1 (strongly disagree) to 7 (strongly agree). Scores will be averaged to create a composite score (possible range 1 to 7). Higher scores indicate greater maladaptive attitudes for drinking.

    Time frame: Change from Baseline Pre PFI Completion to 3-months Post PFI Completion

07

Study locations

1 of 1 sites recruiting
  • RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity
    Houston, Texas 77204, United States
    • Maxwell S Suffis, M.A. · Contact · mssuffis@cougarnet.uh.edu · 206-795-8350
    • Michael J Zvolensky, Ph.D. · Principal investigator
    • Richard A Brown, Ph.D. · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — There are currently no plans to make individual participant data (IPD) available to other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06416059
Lead sponsor
University of Houston
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Responsible party
Michael J. Zvolensky, Ph.D. (Distinguished Professor, University of Houston) — Principal investigator
First posted
May 16, 2024
Start date
May 15, 2023
Primary completion
Jul 31, 2024 (estimated)
Completion
Aug 31, 2024 (estimated)
Last update
Jun 17, 2024

Study contacts

Brooke Y Redmond, Ph.D.
Contact
restorestudy94@gmail.com
713-743-8056
Michael J Zvolensky, Ph.D.
Contact
restorestudy94@gmail.com
713-743-8595
Michael Zvolensky, Ph.D.
principal investigator · University of Houston

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion